Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Menopause

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Disorders of the Female Reproductive System

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

Male Sexual Response: Erection & Ejaculation

Male Sexual Response: Erection & Ejaculation

Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...

Hormonal Regulation of the Menstrual Cycle

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Low thrombin generation in postmenopausal women using estetrol.

Climacteric : the journal of the International Menopause Society·2024

Same author

Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women.

Climacteric : the journal of the International Menopause Society·2022

Same author

[Third- and fourth-degree post-delivery perineal tears : retrospective analysis and management adaptation].

Revue medicale de Liege·2022

Same author

[«I am not pregnant !» About denial of pregnancy…].

Revue medicale de Liege·2020

Same author

[Belgian register and reference centers for gestational trophoblastic diseases].

Revue medicale de Liege·2016

Same author

Exploring the interest in and the usage of the internet among patients eligible for osteoporosis screening.

Calcified tissue international·2015

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

[Female sexual dysfunction and postmenopausal androgen therapy].

S Delcominette¹, U Gaspard

¹ULg, Belgique.

Revue Medicale De Liege

|February 29, 2008

Summary

Androgen therapy shows promise for treating Hypoactive Sexual Desire Disorder (HSDD) in menopausal women. Short-term (6-12 months) treatment appears effective and safe, addressing decreased libido and sexual distress.

Area of Science:

Reproductive Endocrinology
Women's Health
Pharmacology

Context:

Female sexual dysfunction is complex and multifactorial.
Menopause (natural or surgical) and aging contribute to decreased libido.
Hypoactive Sexual Desire Disorder (HSDD) is characterized by low sexual desire and responsiveness causing personal distress.

Purpose:

To review the therapeutic management of HSDD in postmenopausal women.
To evaluate the efficacy and safety of androgen therapy for HSDD.
To discuss optimal androgen administration strategies and safety considerations.

Summary:

Androgen administration, alongside hormone therapy, is explored for HSDD management.
Dosage, type, and route of androgens are optimized to minimize side effects.

Related Experiment Videos

Last Updated: Jul 7, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Recent randomized controlled trials suggest promising efficacy and safety for 6-12 month androgen therapy in HSDD.

Impact:

Provides insights into managing HSDD in postmenopausal women.
Highlights the potential of short-term androgen therapy for improving sexual well-being.
Informs clinical practice regarding the use of androgens for HSDD, emphasizing safety monitoring.